Document Preview Unavailable

Reduced CREB3L2 expression is associated with resistance to sorafenib and poor prognosis in ER-positive breast cancer

Mullarkey, Sean; Arabkari, Vahid; Hossain, Muhammad Mosaraf; Gupta, Sanjeev; Gupta, Ananya.  bioRxiv, Oct 3, 2016.

You might have access to this document